ORIG3N's Series A Round

ORIG3N raised a round of funding on December 09, 2015.

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based …

Articles about ORIG3N's Series A Round: